Global Cell Culture Market: Growing Demand for Artificial Organs to Pave Way for Market’s Growth

The vendor landscape in the global cell culture market includes players such as VWR International LLC, Thermo Fisher Scientific Inc., GE Healthcare, Lonza Group Ltd., Becton, Dickinson & Co., Sigma-Aldrich Co. LLC., Corning Life Sciences B.V., EMD Millipore, PromoCell GmbH, and Wheaton Industries Inc. According to a TMR analyst, mergers and acquisitions among the key players are expected to strengthen the market in the coming years. 

Download Free PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=405

Cell Culture Consumables Register Higher Demand than Serums and Reagents

The market players are registering increased demand for cell culture across the medical research sector. Cell cultures are being increasingly applied across drug screening and monitoring, disease diagnosis, biologic manufacturing, IVF technology, cancer research, and stem cell research. Increased investments by private medical organizations and government organizations have supported the growth of the global cell culture market. TMR states that among the cell culture consumables, cell culture media register the highest demand compared to serums and reagents. This is due to the key importance of the nature of the culture medium to the health of the cells.

3D Cell Culture to Define Future of Global Cell Culture Market

The growing demand for biopharmaceuticals and artificial organs, coupled with the emerging trend towards serum-free, customized and specialty media solutions is the primary factor contributing towards the growth of the global cell culture market. The increasing focus on stem cell research would further expand the scope of the market in future. TMR recommends that the focus on backward integration to conduct in-house research and sustaining pricing pressures amid a weak global economic scenario will open up significant opportunities for the market players.

However, ethical concern over the usage of animal sources in cell culture is one of the major restraints in the growth of the market. The usage of transgenic plants and animals, and stringent process controls will also impede the growth of the market in the years to come. “3D cell culture has the potential to serve as the future growth opportunity for the market and in vitro analysis.” a TMR analyst predicts.

Asia Pacific to Register Highest Demand for Cell Culture

TMR predicts that among the key regions in the global cell culture market, Asia Pacific will register the fastest growth during the period between 2014 and 2022. “The improvement in economic conditions of the developing countries in the Asia Pacific region such as China and India is anticipated to support the market’s growth,” the analyst states. In 2013, North America was the leading region in the market.

Browse Research Insights: http://www.transparencymarketresearch.com/cell-culture-market.html

TMR finds that the various opportunities in the global cell culture market will propel the expansion of the market at a CAGR of 7.1% during the period from 2014 to 2022. This would lead to an increase in the valuation of the market from US$6.1 bn in 2013 to US$11.3 bn in 2022.

Prevention-Better-than-Cure Sentiment to Help Ultraviolet Germicidal Irradiation Systems Sales Touch New High, says TMR

The key players holding the lion’s share in the global ultraviolet germicidal irradiation market are America Ultraviolet, GE Water & Process Technologies, and UltraViolet Devices, Inc. amongst others, TMR finds in a new report. The majority of these companies will focus on offering effective and cost-efficient products to tap the unmet needs in the overall market. For instance, GE Water & Process Technologies is adopting advanced H-technology to improve its line of products and services to gain a competitive edge in the overall vendor landscape. The global UVGI market will also witness a broader range of products in the coming years to appeal to a wider segment of consumers.

Download Free Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10826

Prevention of Diseases Augments UVGI Market

The noteworthy technological advancements in the UVGI systems have made them a popular choice for sterilization process in restaurants, air-conditioned offices, food joints, hospitals, and several manufacturing units. Consumers are opting for installing hi-tech UVGI systems in order to prevent the occurrence of dangerous airborne diseases, reducing the maintenance cost of HVAC, and mitigating the chances of microbial contamination through air vents.

The rising number of hospital-acquired infections (HAIs) is also driving the global UVI market. According to statistics published by the World Health Organization (WHO) in 2013, about seven patients out every 100 admitted in hospitals acquire HAIs. The global UVGI market will growth at an unprecedented rate against the backdrop of these factors.

Import-related Hurdles to Restrain Market

The biggest challenge faced by this market are the hurdles in developing countries to import UVGI systems. Furthermore, these countries also have a dearth of skilled labor that has the technical knowledge of installing and maintaining these systems. Therefore, the majority of the developing countries have to depend on outsourcing help, which increases the installation costs.

All of these factors are hampering the growth of the UVGI market in emerging economies. Global players are also suffering as several developing countries are formulating new policies to support local manufacturers. This shift in preference is setting a trend in countries of Latin America and Asia Pacific.

A TMR analyst states, “The global UVGI market does have a lineup of some lucrative opportunities such as the burgeoning demand from water purification and advanced packaging sector that are looking at ways to avert air and borne diseases.” The unfortunate reduction in sources of fresh water sources, water pollution, and air pollution have collectively created a demand for UVGI in the food and beverages packaging sectors.

According to TMR’s report, the opportunity in the global ultraviolet germicidal irradiation market was valued at US$168.4 mn in 2014. By the end of 2023, its valuation is anticipated to reach US$430.3 mn, rising at a CAGR of 10.9%between 2015 and 2023. The air disinfectant UVGI systems are expected to make a significant contribution to the growth of this market as its valuation will likely rise to US$375.2 mn by 2023.

The analysis of the market drivers and restraints in the global UVGI market is based on the findings of a report published by Transparency Market Research. The report is titled “Ultraviolet Germicidal Irradiation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023.”

TMR Releases Research Paper, “Scar Treatment Market” – Evolving Trends 2024

Often considered a concept that draws from wound care and first aid, scar treatment has emerged as a niche market promising high growth to medical device manufacturers. However, products used in scar therapy are far more advanced than conventional first-aid adhesives. Driven by innovations, demand in the U.S. scar treatment market is poised to surge exponentially between 2016 and 2024.

Free PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12509  

A scar is any mark on the skin caused by injury, burns, surgery, acne, or inflammation of tissue. Scars

can impact the mental and physical well-being of an individual, resulting in poor self-esteem, depression, embarrassment, and altered social interactions. Scars can be of various types depending on their age, color, shape, and sizes. The incidence of skin problems leading to scar formation is significantly high in the U.S., which is driving the scar treatment market in the country.

Additionally, the U.S. scar treatment market is significantly gaining from the easy availability of technologically advanced products with the capability of fading apparent scars. The growing geriatric population and rising consciousness about appearance among consumers are also aiding the expansion of the scar treatment market in the U.S. Increasing expenditure on personal grooming also has been boosting the U.S. scar treatment market.

A comprehensive overview of the U.S. scar treatment market has been provided in the report. The factors impacting the market’s growth are studied in detail. The report also presents insights into the growth drivers and restraints that are expected to influence the market’s trajectory during the forecast period. Some of the companies operating in the market are profiled in the report to examine the competition prevailing in the U.S. scar treatment market.

The increasing disposable income of consumers and rising economic growth are cited as reasons for the revenue generated from the increasing sale of scar treatment products. It is important to note that while the treatment of keloids and burn scars is considered medically important by regulatory bodies, the treatment of mild to medium acne and spot correction is not considered a medical necessity. However, a rise in the affluence of the population has been fuelling the demand for aesthetic corrective procedures such as dermal filling, wrinkle reduction, volume restoration, and laser treatment.

Botulinum type-A injections and hyaluronic acid based dermal fillers are primarily used for aesthetically improving a person’s appearance.

Browse Research Report: http://www.transparencymarketresearch.com/scar-treatment-market.html

The U.S. scar treatment market is also significantly gaining from the increasing demand for combination therapeutics in scar treatment to enhance the effectiveness of procedures and shorten the time taken for treatment.

The various products available in the U.S. scar treatment market include ointments, creams, gels, oils, and sprays. These products have proven helpful in reducing redness, bumps, pain, and itching caused by scars. Since these products can mostly be applied onto scars without any medical supervision, demand for them is quite high in the U.S. Additionally, the demand for minimally invasive surgical treatments and laser treatments has also significantly increased for the treatment of more severe scars.  

On the flip side, some of restraints witnessed by the market include the increasing awareness about the side effects associated with the usage of scar treatment products. The high cost of scar treatment therapies also has an adverse impact on the scar treatment market in the U.S.